Dr. Matthew Simunovic presented the results of the First-In-Human Trial to a global audience at the RANZCO 2025 congress in Melbourne. Dr. Simunovic was a primary investigator in the First-In-Human study and performed the first ever LensOne™ surgery. He currently holds professorial roles at the University of Sydney and UNSW and senior clinical appointments at Sydney Eye Hospital and Sydney Children’s Hospitals Network.
Title: “First in Human Outcomes of a Sutureless, Scleral-foxated Prosthetic Capsular Bag”
Speaker: Matthew Simunovic, MD, PhD
Date: November 2025
Location: Sydney, Australia
Dr. Lejla Vajzovic presented LensOne™ study outcomes from the First-In-Human Trial at the FLORetina meeting in December 2025. Dr. Vajzovic is an associate professor at Duke University specializing in vitreoretinal disease and complex surgical management of anterior and posterior segment pathology.
Title: “Early Clinical Results of a Novel Scleral-fixated Prosthetic Capsular Bag”
Speaker: Lejla Vajzovic, MD
Date: December 2025
Location: Florence, Italy
Dr. Simunovic gave his second presentation of the First-In-Human study outcomes at the annual congress for the Asia-Pacific Academy of Ophthalmology in February 2026.
Title: “Replacing the Capsular Bag in Aphakia: First-In-Human Results”
Speaker: Matthew Simunovic, MD, PhD
Date: February 2026
Location: Hong Kong, China